These constraints in the BTNX NTS are very applicable, as we discovered e.g. etodesnitazene to have an analogous in vitro potency and efficacy as fentanyl [7, thirteen] and as it may likely give PWUD a Untrue perception of safety. On top of that, the detectability of nitazene analogues in drug samples could possibly be impacted by solubility challe